Formulating Poorly Water Soluble Drugs (Aaps Advances In The Pharmaceutical Sciences Series, 50) - 9783030887216
Springer
ISBN13:
9783030887216
$263.20
The objective of this third edition is to consolidate within a single text the most current knowledge, practical methods, and regulatory considerations pertaining to formulations development with poorly water-soluble molecules. A pharmaceutical scientists approach toward solubility enhancement of a poorly water-soluble molecule typically includes detailed characterization of the compounds physiochemical properties, solid-state modifications, advanced formulation design, non-conventional process technologies, advanced analytical characterization, and specialized product performance analysis techniques. The scientist must also be aware of the unique regulatory considerations pertaining to the non-conventional approaches often utilized for poorly water-soluble drugs. One faced with the challenge of developing a drug product from a poorly soluble compound must possess at a minimum a working knowledge of each of the above mentioned facets and detailed knowledge of most. In light of the magnitude of the growing solubility problem to drug development, this is a significant burden especially when considering that knowledge in most of these areas is relatively new and continues to develop.
- | Author: Robert O. Williams Iii, Daniel A. Davis Jr., Dave A. Miller
- | Publisher: Springer
- | Publication Date: May 20, 2023
- | Number of Pages: 705 pages
- | Language: English
- | Binding: Paperback
- | ISBN-10: 3030887219
- | ISBN-13: 9783030887216
- Author:
- Robert O. Williams Iii, Daniel A. Davis Jr., Dave A. Miller
- Publisher:
- Springer
- Publication Date:
- May 20, 2023
- Number of pages:
- 705 pages
- Language:
- English
- Binding:
- Paperback
- ISBN-10:
- 3030887219
- ISBN-13:
- 9783030887216